Literature DB >> 6641099

Diazepam loading: simplified treatment of alcohol withdrawal.

E M Sellers, C A Naranjo, M Harrison, P Devenyi, C Roach, K Sykora.   

Abstract

Alcohol withdrawal therapy can be simplified with a loading dose of diazepam, taking advantage of the kinetic tapering afforded by the drug's long t 1/2s and its metabolites, and of the effectiveness of nonpharmacologic maneuvers. In a double-blind trial, 50 inpatients in moderate to severe alcohol withdrawal received 20 mg oral diazepam and supportive care (n = 25) or placebo and supportive care (n = 25) every 2 hr until they were asymptomatic. Fifty-six percent of patients responded to placebo within 5 +/- 2.9 hr (mean +/- SD), whereas 72% responded to initial diazepam within 6.3 +/- 3.9 hr. Patients treated with diazepam had more rapid and greater improvement than those treated with placebo. Patients who did not respond to six doses of diazepam received further (unblinded) diazepam, 20 mg, every 1 to 2 hr. All patients who did not initially respond (n = 18) improved after more diazepam. Thus all patients who received diazepam (n = 36), during the experimental phase or subsequently, were effectively treated. There were no adverse effects. The median number of 20-mg diazepam doses to treat alcohol withdrawal were three, given over a period of 7.6 hr (range = 1 to 12 and 0.33 to 45 hr). Complications occurred only in those who received placebo during the experimental phase, indicating that delay in therapy may be responsible for the appearance of complications in alcohol withdrawal.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6641099     DOI: 10.1038/clpt.1983.256

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  28 in total

Review 1.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

Review 2.  The drug management of severe alcohol withdrawal syndrome.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

3.  Alcohol withdrawal treatment practices.

Authors:  A A Wartenberg
Journal:  J Gen Intern Med       Date:  1996-05       Impact factor: 5.128

Review 4.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

5.  Another perspective on management of withdrawal.

Authors:  D Bates
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

6.  Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population.

Authors:  Manu Jose; Jayanthi Mathaiyan; Shivanand Kattimani; Surendiran Adithan; Adithan Chandrasekaran
Journal:  Eur J Clin Pharmacol       Date:  2016-04-20       Impact factor: 2.953

Review 7.  Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment.

Authors:  R C Turner; P R Lichstein; J G Peden; J T Busher; L E Waivers
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

8.  Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal.

Authors:  Enrico Sanna; Maria Cristina Mostallino; Fabio Busonero; Giuseppe Talani; Stefania Tranquilli; Manuel Mameli; Saturnino Spiga; Paolo Follesa; Giovanni Biggio
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

Review 9.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Prevention of alcohol withdrawal seizures with oral diazepam loading.

Authors:  P Devenyi; M L Harrison
Journal:  Can Med Assoc J       Date:  1985-04-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.